It has been demonstrated that miR-23a-3p targets the expression of acyl-CoA synthetase long-chain family member 4, consequently inhibiting ROS generation, alleviating ferroptosis in HCC, and enhancing HCC resistance to sorafenib [35]. Here, ACSL4 is linked to hepatocellular carcinoma.